|
UNITED
STATES |
OMB APPROVAL |
|
OMB Number: 3235-0578 |
|
|
Expires: April 30, 2013 |
|
|
Estimated average burden hours per response........5.6 |
FORM N-PX
ANNUAL
REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811- 04889
H&Q Healthcare Investors
(Exact name of registrant as specified in charter)
2 Liberty Square, 9th Floor, Boston, MA |
|
02109 |
(Address of principal executive offices) |
|
(Zip code) |
Laura Woodward
H&Q Healthcare Investors
2 Liberty Square, 9th Floor, Boston MA 02109
(Name and address of agent for service)
Registrants telephone number, including area code: 617 772-8500
Date of fiscal year end: September 30
Date of reporting period: 7/1/09-6/30/10
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss.239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrants proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (OMB) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
HQH N-PX for the period July 1, 2009 to June 30, 2010
CUSIP |
|
Symbol |
Company Name |
|
|
||
002824100 |
|
ABT |
Abbott Laboratories |
|
|
||
Meeting Date: |
4/23/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
2/24/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To elect R.J. Alpern |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect R.S. Austin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect W.M Daley |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect W.J. Farrell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect H.R. Fuller |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect W.A. Osborn |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect D.A.L Owen |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect R.S. Roberts |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect S.C. Scott III |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect W.D Smithburg |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect G.F Tilton |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect M.D. White |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of Deloitte & Touche LLP as Auditors |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Shareholder proposal-advisory vote |
|
Against |
|
Yes |
|
For |
|
Shareholder |
4 |
|
Shareholder proposal-special shareholder meetings |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
00484M106 |
|
ACOR |
Acorda Therapeutics, Inc. |
|
|
||
Meeting Date: |
6/9/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/14/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To elect John P. Kelley |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Sandra Panem, Ph.D |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Wise Young, Ph.D. , M.D. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the appointment of Ernst & Young LLP as the companys independent auditors for the fiscal year ending December 31, 2010. |
|
For |
|
Yes |
|
For |
|
Management |
00817Y108 |
|
AET |
Aetna Inc. |
|
|
||
Meeting Date: |
5/21/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/19/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Frank M. Clark |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Betsy Z. Cohen |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Molly J. Coye, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Roger N. Farah |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Barbara Hackman Franklin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jeffrey E. Garten |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Earl G. Graves |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gerald Greenwald |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ellen M. Hancock |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard J. Harrington |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Edward J. Ludwig |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Joseph P. Newhouse |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ronald A. Williams |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of independent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Approval of Aetna Inc. 2010 stock incentive Plan |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Approval of Aetna Inc. 2010 non-employee director compensation plan |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Approval of Aetna Inc. 2010 annual incentive plan performance criteria |
|
For |
|
Yes |
|
For |
|
Management |
6 |
|
Shareholder proposal on cumulative voting |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
7 |
|
Shareholder proposal on independent chairman |
|
Against |
|
Yes |
|
For |
|
Stockholder |
009728106 |
|
AKRX |
Akorn Inc |
|
|
||
Meeting Date: |
8/7/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
6/15/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To re-elect John N. Kappor, PH.D |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Jerry N. Ellis |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Ronald M. Johnson |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Subhash Kapre, PH. D |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Brian Tambi |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Steven J. Meyer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Alan Weinstein |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Randall J. Wall |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the selection of Ernst & Young LLP to serve as Akorns independent registered public accounting firm for the fiscal year ending December 31, 2009. |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Approval of an amendment to the companys 2003 amended and restated stock option plan to increase the total number of shares authorized and reserved for inssurance by 6,000,000 shares. |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Approval of an amendment to the companys amended and restated employee stock purchase plan to increase the total number of shares authorized and reserved for inssurance by 1,000,000 shares. |
|
For |
|
Yes |
|
For |
|
Management |
009728106 |
|
AKRX |
Akorn Inc |
|
|
||
Meeting Date: |
5/21/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/7/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To re-elect John N. Kappor, PH.D |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Ronald M. Johnson |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Brian Tambi |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Steven J. Meyer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To re-elect Alan Weinstein |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Kenneth S. Abraowitz |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the selection of Ernst & Young LLP to serve as Akorns independent registered public accounting firm for the fiscal year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Approval of the grant of non-qualified stock options to Akorns interim Chief Executive Officer, Rajat Rai |
|
For |
|
Yes |
|
For |
|
Management |
015351109 |
|
ALXN |
Alexion Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/12/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/17/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Leonard Bell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Max Link |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William R. Keller |
|
|
|
|
|
|
|
|
1 |
|
Elect director Joseph A. Madri |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Larry L. Mathis |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director R. Douglas Norby |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alvin S. Parven |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Andreas Rummelt |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of the Amendment to 2004 incentive plan, as described in the accompanying proxy statement, including to increase the number of shares of common stock available for issuance by 3 million shares (subject to adjustment in the event of stock splits and other similar events) |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Ratification of appointment by the board of directors of PricewaterhouseCoopers LLP as Alexions independent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
016255101 |
|
ALGN |
Align Technology, Inc. |
|
|
||
Meeting Date: |
5/20/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/23/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director David E. Collins |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Joseph Lacob |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C. Raymond Larkin, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George J. Morrow |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dr. David Nagel |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Thomas M. Prescott |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Greg J. Santora |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Warren S. Thaler |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.s independent registered public accountants for the fiscal year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Proposal to approve amended and restated 2005 equity incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Proposal to approve 2010 employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
01642T108 |
|
ALKS |
Alkermes, Inc. |
|
|
||
Meeting Date: |
10/6/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
7/24/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director David W. Anstice |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Floyd E. Bloom |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert A. Breyer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dvid A. Broeckert |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Geraldine Henwood |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Paul J. Mitchell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard F. Pops |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alexander Rich |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Mark B. Skaletsky |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael A. Wall |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify PricewaterhouseCoopers LLP as the companys independent registered public accountant for fiscal year 2010 |
|
For |
|
Yes |
|
For |
|
Management |
031162100 |
|
AMGN |
Amgen Inc. |
|
|
||
Meeting Date: |
5/12/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/15/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Dr. David Baltimore |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frank J. Biondi, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Francois de Carbonnel |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jerry D. Choate |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dr. Vance D. Coffman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frederick W. Gluck |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dr. Rebecca M. Henderson |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frank C. Herringer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dr. Gilbert S. Omenn |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Judity C. Pelham |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Adm. J. paul Reason, UsN |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Leonard D. Schaeffer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kevin W. Sharer |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
3A |
|
Stockholder proposal #1 (Action by Written Consent) |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
3B |
|
Stockholder proposal #2 (Equity retention policy) |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
05365U101 |
|
AVTQY |
Aveta Inc, |
|
|
||
Meeting Date: |
3/9/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
2/16/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To elect Daniel E. Straus |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Joseph D. Mark |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Jonathan Kolatch |
|
For |
|
Yes |
|
For |
|
Management |
75887109 |
|
BDX |
Becton Dickinson and Company |
|
|
||
Meeting Date: |
2/2/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
12/11/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To elect Henry P. Becton, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Edward F. Degraan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Claire M. Fraser-Liggett |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Edward J. Ludwig |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Adel A.F. Mahmoud |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect James F. Orr |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Willard J. Overlock, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
To elect Bertram L. Scott |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of selection of independent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Approval of a by-law amendment regarding special shareholder meetings |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Approval of an amendment to the 2004 employee and director equity-based compensation plan |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Approval of material terms of performance goals |
|
|
|
|
|
|
|
|
6 |
|
Majority voting |
|
Against |
|
Yes |
|
For |
|
Stockholder |
7 |
|
Cumulative voting |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
151020104 |
|
CELG |
Celgene Corporation |
|
|
||
Meeting Date: |
6/16/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/20/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Sol J. Barer, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert J. Hugin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael D. Casey |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Carrie S. Cox |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Rodman L. Drake |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gilla Kaplan, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director James J. Loughlin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ernest Mario, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Walter L. Robb, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of the appointment of KPMG LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
156708109 |
|
CEPH |
Cephalon, Inc. |
|
|
||
Meeting Date: |
5/20/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/25/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director F. Baldino, Jr., Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William P. Egan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Martyn D. Greenacre |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Vaughn M. Kailian |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kevin E. Moley |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C.A. Sanders, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gail R. Wilensky, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dennis L. Winger |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of amendment to the 2004 equity compensation plan increasing the number of shares authorized for issuance |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Approval of Cephalon, Inc.s 2010 employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accountants for the year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
159864107 |
|
CRL |
Charles River Laboratories, Intl., Inc. |
|
|||
Meeting Date: |
5/6/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/18/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director James C. Foster |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Nancy T. Chang |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Stephen D. Chubb |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Deborah T. Kochevar |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George E. Massaro |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George M. Milne, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C. Richard Reese |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect Director Douglas E. Rogers |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect Director Samuel O. Their |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William H. Waltrip |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the appointment of PricewaterhouseCoopers LLP as the companys independent registered public accountants for the year ending December 25, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
18725U109 |
|
CLDA |
Clinical Data, Inc. |
|
|
||
Meeting Date: |
9/17/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
7/22/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Andrew J. Fromkin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Larry D. Horner |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Randal J. Kirk |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Arthur B. Malman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Burton E. Sobel, M.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Scott L. Tarriff |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard J. Wallace |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the appointment of Deloitte & Touche LLP as Clinical Datas independent registered public accounting firm for the 2010 fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
N/A N/A |
Concentric Medical, Inc. |
|
|
Action by Written Consent: |
9/30/2009 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of 2009 Equity Incentive Plan |
|
For |
|
Yes |
|
For |
|
Management |
229678107 |
|
CBST |
Cubist Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/10/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/15/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Michael Bonney |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Mark Corrigan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Sylvie Gregoire |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
A proposal to amend our 2010 equity incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
A proposal to approve our performance-based management incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
A proposal to ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
126650100 |
|
CVS |
CVS Caremark Corporation |
|
|
||
Meeting Date: |
5/12/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/15/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Edwin M. Banks |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C. David Brown II |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David W. Dorman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kristen Gibney Williams |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Marian L. Heard |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William H. Joyce |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jean-Pierre Millon |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Terrence Murray |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C.A. Lance Piccolo |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Sheli Z. Rosenberg |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Thomas M. Ryan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard J. Swift |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the 2010 fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Proposal to adopt the companys 2010 incentive compensation plan |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Proposal to adopt an amendment to the companys charter to allow Stockholders to call special meetings |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Stockholder proposal regarding a report on political contributions and expenditures |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
6 |
|
Stockholder proposal regarding principles to stop global warming |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
N/A N/A |
Eleme Medical Inc. |
|
|
Action by Written Consent: |
12/18/2009 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Note financing |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Wavier of right of first offer |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
General authorization |
|
For |
|
Yes |
|
For |
|
Management |
N/A N/A |
Eleme Medical Inc. |
|
|
Action by Written Consent: |
6/4/2010 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Note financing |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Wavier of right of first offer |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
General authorization |
|
For |
|
Yes |
|
For |
|
Management |
N/A N/A |
FlowCardia, Inc. |
|
|
Action by Written Consent: |
3/26/2010 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of amendment to fifth amended and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
General authority and ratification |
|
For |
|
Yes |
|
For |
|
Management |
|
345838106 |
|
FRX |
Forest Laboratories |
|
|
||
Meeting Date: |
8/10/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
6/19/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Howard Solomon |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Lawrence S. Olanoff, MD, Phd |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Nesli Basgoz, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William J. Candee, III |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George S. Cohen |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dan L. Goldwasser |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kenneth E. Goodman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Lester B. Salans, MD |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of the companys executive compensation philosophy, policies and procedures as described in the Compensation Discussion and Analysis |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Ratification of the selection of BDO Seidman, LLP as independent registered public accounting firm for the fiscal year ending March 31, 2010. |
|
For |
|
Yes |
|
For |
|
Management |
372917104 |
|
GENZ |
Genzyme Corporation |
|
|
||
Meeting Date: |
6/16/2010 |
|
Meeting Type: |
Contested-Annual |
|||
Record Date: |
4/9/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Douglas A. Berthiaume |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert J. Bertolini |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gail K. Boudreaux |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert J. Carpenter |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Charles L. Cooney |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Victor J. Dzau |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Senator Connie Mack III |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard F. Syron |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Henri A. Termeer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ralph V. Witworth |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
A proposal to amend the 2004 equity incentive plan to increase the number of shares of common stock available for issuance under the plan by 2,750,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
A proposal to approve the 2009 employee stock purchase plan to increase the number of shares of common stock available for issuance under the plan by 1,500,000 |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
A proposal to amend the 2007 directors equity plan to increase the number of shares of common stock available for issuance under the plan by 250,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
A proposal to amend the restated articles of organization to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 90% to 40% |
|
For |
|
Yes |
|
For |
|
Management |
6 |
|
A proposal to ratify the audit committees selection of independent auditors for 2010 (PricewaterhouseCoopers LLP) |
|
For |
|
Yes |
|
For |
|
Management |
372917104 |
|
GENZ |
Genzyme Corporation |
|
|
||
Meeting Date: |
6/16/2010 |
|
Meeting Type: |
Contested-Annual |
|||
Record Date: |
4/9/2010 |
|
|
|
|||
# |
|
Proposal |
|
Oppostion Rec. |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Dr. Steven Burakoff |
|
For |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Dr. Alexander J. Denner |
|
For |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Carl C. Icahn |
|
For |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Dr. Richard Mulligam |
|
For |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Douglas A. Berthiaume |
|
For |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Robert J. Bertolini |
|
For |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Gail K. Boudreaux |
|
For |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Robert J. Carpenter |
|
For |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Victor J. Dzau |
|
For |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Ralph V. Witworth |
|
For |
|
No |
|
None |
|
Opposition |
2 |
|
A proposal to amend the 2004 equity incentive plan to increase the number of shares of common stock available for issuance under the plan by 2,750,000 shares |
|
For |
|
No |
|
None |
|
Management |
3 |
|
A proposal to approve the 2009 employee stock purchase plan to increase the number of shares of common stock available for issuance under the plan by 1,500,000 |
|
For |
|
No |
|
None |
|
Opposition |
4 |
|
A proposal to amend the 2007 directors equity plan to increase the number of shares of common stock available for issuance under the plan by 250,000 shares |
|
For |
|
No |
|
None |
|
Management |
5 |
|
A proposal to amend the restated articles of organization to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 90% to 40% |
|
For |
|
No |
|
None |
|
Management |
6 |
|
A proposal to ratify the audit committees selection of independent auditors for 2010 (PricewaterhouseCoopers LLP) |
|
For |
|
No |
|
None |
|
Management |
375558103 |
|
GILD |
Gilead Sciences, Inc. |
|
|
||
Meeting Date: |
5/11/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/15/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Paul Berg |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director John F. Cogan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Etienne F. Davignon |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director James M. Denny |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Carla A. Hills |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kevin E. Lofton |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director John W. Madigan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director John C. Martin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gordon E. Moore |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Nicholas G. Moore |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard J. Whitley |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gayle E. Wilson |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Per Wold-Olsen |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of Ernst & Young LLP by the audit committee of the board of directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
If properly presented at the meeting, to vote on a stockholder proposal requesting that the board take steps to adopt majority voting standards in Gileads certificate of incorporation and by-laws |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
436440101 |
|
HOLX |
Hologic, Inc. |
|
|
||
Meeting Date: |
3/3/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
1/8/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director John W. Cumming |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert A. Cascella |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Sally W. Crawford |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David R. Lavance, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Nancy L. Leaming |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Lawrence M. Levy |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Glenn P. Muir |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Elaine S. Ullian |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Wayne Wilson |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To consider and act upon ratification of the appointment of Ernst & Young LLP as Hologics independent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To consider and act upon the adjournment of the annual meeting |
|
For |
|
Yes |
|
For |
|
Management |
45103T107 |
|
ICLR |
ICON plc |
|
|
||
Meeting Date: |
7/20/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
6/10/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To receive the accounts and reports |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To re-elect Dr. Ronan Lambe |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To re-elect Dr. Peter Gray |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
To re-elect Dr. Anthony Murphy |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
To authorize the fixing of the auditors renumeration |
|
For |
|
Yes |
|
For |
|
Management |
6 |
|
To authorize the company to allot shares |
|
For |
|
Yes |
|
For |
|
Management |
7 |
|
To display the statutory pre-emption rights |
|
For |
|
Yes |
|
For |
|
Management |
8 |
|
To authorize the company to make market purchases of shares |
|
For |
|
Yes |
|
For |
|
Management |
45168D104 |
|
IDXX |
IDEXX Laboratories, Inc. |
|
|
||
Meeting Date: |
5/5/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/8/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Jonathan W. Ayers |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert J. Murray |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Joseph V. Vumbacco |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection by the audit committee of the board of directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the current fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
452327109 |
|
ILMN |
Illumina, Inc. |
|
|
||
Meeting Date: |
5/12/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/19/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Paul C. Grint, M.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David R. Walt, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratify the appointment of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending January 2, 2011 |
|
For |
|
Yes |
|
For |
|
Management |
46120E602 |
|
ISRG |
Intuitive Surgical, Inc. |
|
|
||
Meeting Date: |
4/21/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
2/22/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Alan J. Levy |
|
Yes |
|
For |
|
Yes |
|
Management |
1 |
|
Elect director Eric H. Halvorson |
|
Yes |
|
For |
|
Yes |
|
Management |
1 |
|
Elect director Amal M. Johnson |
|
Yes |
|
For |
|
Yes |
|
Management |
2 |
|
To approve the companys 2010 incentive award plan |
|
Yes |
|
For |
|
Yes |
|
Management |
4.78E+08 |
|
JNJ |
Johnson & Johnson |
|
|
||
Meeting Date: |
4/22/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
2/22/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Mary Sue Coleman |
|
Yes |
|
For |
|
Yes |
|
Management |
1 |
|
Elect director James G. Cullen |
|
Yes |
|
For |
|
Yes |
|
Management |
1 |
|
Elect director Micheal M.E. Johns |
|
Yes |
|
For |
|
Yes |
|
Management |
1 |
|
Elect director Susan L. Lindquist |
|
Yes |
|
For |
|
Yes |
|
Management |
1 |
|
Elect director Anne E. Mulcahy |
|
Yes |
|
For |
|
Yes |
|
Management |
1 |
|
Elect director Leo F. Mullin |
|
Yes |
|
For |
|
Yes |
|
Management |
1 |
|
Elect director William D. Perez |
|
Yes |
|
For |
|
Yes |
|
Management |
1 |
|
Elect director Charles Prince |
|
Yes |
|
For |
|
Yes |
|
Management |
1 |
|
Elect director David Satcher |
|
Yes |
|
For |
|
Yes |
|
Management |
2 |
|
Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2010 |
|
Yes |
|
For |
|
Yes |
|
Management |
3 |
|
Advisory vote on executive compensation |
|
Against |
|
Yes |
|
For |
|
Stockholder |
4 |
|
Special shareowner meeting |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
N/A N/A |
Labcyte Inc. |
|
|
Action by Written Consent: |
10/1/2009 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of the loan agreement |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of issuance of the warrant |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of waiver of right of first offer |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Omnibus resolution |
|
For |
|
Yes |
|
For |
|
Management |
|
50540R409 |
|
LH |
Laboratory Corp. of America Holdings |
|
|||
Meeting Date: |
5/12/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/15/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Thomas P. MacMahon |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kerrii B. Anderson |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jean-Luc Belingard |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David P. King |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Wendy E. Lane |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert E. Mittelstaedt, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Arthur H. Rubenstein, Mbbch |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director M. Keith Weikel, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director R. Sanders Williams, MD |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as the companys independent registered public accounting firm for 2010 |
|
For |
|
Yes |
|
For |
|
Management |
53217V109 |
|
LIFE |
Life Technologies Corporation |
|
|
||
Meeting Date: |
4/29/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/1/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director George F. Adam, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Raymond V. Dittamore |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Arnold J. Levine, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Bradley G. Lorimier |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David D. UPrichard, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of the appointment of Ernst & Young LLP as independent auditors of the company for fiscal year 2010 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Adoption of an amendment to the restated certificate of incorporation of the company (adopt majority voting for uncontested elections of directors) |
|
For |
|
Yes |
|
Against |
|
Management |
4 |
|
Adoption of amendments to the restated certificate of incorporation of the company (eliminate supermajority provisions) |
|
For |
|
Yes |
|
Against |
|
Management |
5 |
|
Adoption of amendments to the bylaws of the company (adopt majority voting for uncontested elections of directors) |
|
For |
|
Yes |
|
Against |
|
Management |
6 |
|
Adoption of an amendment to the bylaws of the company (eliminate supermajority provisions) |
|
For |
|
Yes |
|
Against |
|
Management |
7 |
|
Adoption of the companys 2010 incentive compensation plan |
|
For |
|
Yes |
|
Against |
|
Management |
572901106 |
|
MATK |
Martek Biosciences Corporation |
|
|
||
Meeting Date: |
3/18/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
1/19/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Harry J. DAndrea |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director James R. Beery |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael G. Devine |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Steve Dubin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert J. Flanagan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Polly B. Kawalek |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jerome C. Keller |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Douglas J. Macmaster, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert H. Mayer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David M. Pernock |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Eugene H. Rotberg |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year 2010 |
|
For |
|
Yes |
|
For |
|
Management |
574795100 |
|
MASI |
Masimo Corporation |
|
|
||
Meeting Date: |
6/2/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/15/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Joe Kiani |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jack Lasersohn |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of Grant Thornton LLP as the companys independent auditors for fiscal year 2010 |
|
For |
|
Yes |
|
For |
|
Management |
58405U102 |
|
MHS |
Medco Health Solutions, Inc. |
|
|
||
Meeting Date: |
5/12/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/15/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Howard W. Barker, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director John L. Cassis |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael Goldstein |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Charles M. Lillis |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Myrtle S. Potter |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William L. Roper |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David B. Snow, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David D. Stevens |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Blenda J. Wilson |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the company for the 2010 fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Approval of an Amendment to the certificate of incorporation to permit shareholders to call special meetings |
|
For |
|
Yes |
|
For |
|
Management |
628530107 |
|
MYL |
Mylan Inc. |
|
|
||
Meeting Date: |
5/14/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/25/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Mark W. Parrish |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert J. Coury |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Wendy Cameron |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Neil Dimick, CPA |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Doug Leech, CPA |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Joseph C. Maroon, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Rodney L. Piatt, CPA |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C.B. Todd |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director R.L. Vanderveen, Ph.D. R.Ph. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Stockholder |
3 |
|
Shareholder proposal-advisory (non-binding) vote on executive compensation |
|
Against |
|
Yes |
|
For |
|
Stockholder |
4 |
|
Shareholder proposal- retention of executive equity compensation |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
62855J104 |
|
MYGN |
Myriad Genetics, Inc. |
|
|
||
Meeting Date: |
11/5/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
9/15/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director John T. Henderson, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director S. Louise Phantiel |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to amend the 2003 employee, director and consutant stock option plan to increase the number of shares of common stock available for issuance thereunder by 3,000,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Proposal to ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year ending June 30, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
N/A N/A |
Palyon Medical Corporation |
|
|
Action by Written Consent: |
8/26/2009 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Authorization of amended and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
N/A N/A |
Palyon Medical Corporation |
|
|
Action by Written Consent: |
5/10/2010 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Board of directors appointments and designations |
|
For |
|
Yes |
|
For |
|
Management |
|
709754105 |
|
PPCO |
Penwest Pharmaceuticals Co. |
|
|
||
Meeting Date: |
6/22/2010 |
|
Meeting Type: |
Annual- Contested |
|||
Record Date: |
4/30/2010 |
|
|
|
|||
# |
|
Proposal |
|
Opposition Rec. |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Roderick Wong M.D. |
|
For |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Saiid Zarrabian |
|
For |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director John G. Lemkey |
|
For |
|
Withheld |
|
None |
|
Opposition |
2 |
|
Ratification of the appointment of Ernst & Young LLP as the independent Public Accountants of the company for the fiscal year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Opposition |
709754105 |
|
PPCO |
Penwest Pharmaceuticals Co. |
|
|
||
Meeting Date: |
6/22/2010 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/30/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Christopher M. Bianchi |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Paul E. Freidman |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Jennifer L. Good |
|
For |
|
No |
|
None |
|
Management |
2 |
|
Ratification of the appointment of Ernst & Young LLP as the independent Public Accountants of the company for the fiscal year ending December 31, 2010 |
|
For |
|
No |
|
None |
|
Management |
714046109 |
|
PKI |
Perkinelmer, Inc. |
|
|
||
Meeting Date: |
4/27/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/1/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Robert F. Friel |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Nicholas A. Lopardo |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alexis P. Michas |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director James C. Mullen |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dr. Vicki L. Sato |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gabriel Schmergel |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kenton J. Sicchitano |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Patrick J. Sullivan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director G. Robert Tod |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the appointment of Deloitte & Touche LLP as Perkinelmers independent auditors for the current fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
714290130 |
|
PRGO |
Perrigo |
|
|
||
Meeting Date: |
10/29/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
9/4/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Gary M. Cohen |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David T. Gibbons |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ran Gottfried |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ellen R. Hoffing |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of the appointment of Ernst & Young LLP as the independent Public Accountants of the company for the fiscal year 2010 |
|
For |
|
Yes |
|
For |
|
Management |
717081103 |
|
PFE |
Pfizer Inc. |
|
|
||
Meeting Date: |
4/22/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
2/23/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Dennis A. Ausiello |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael S. Brown |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director M. Anthony Burns |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert N. Burt |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director W. Don Cornwell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frances D. Fergusson |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William H. Gray, III |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Constance J. Horner |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director James M. Kilts |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jeffrey B. Kindler |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George A. Lorch |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director John P. Mascotte |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Suzanne Nora Johnson |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Stephen W. Sanger |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William C. Steere, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the selection of KPMG LLP as independent registered public accounting firm for 2010 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Adviosry vote on executive compensation |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Approval of by-law amendment to reduce the percentage of shares required |
|
For |
|
Yes |
|
For |
|
Management |
|
|
for shareholders to call special meetings |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Shareholder proposal regarding stock options |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
717124101 |
|
PPDI |
Pharmaceutical Product Development, Inc. |
|
|||
Meeting Date: |
5/20/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/19/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Stuart Bondurant, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frederic N. Eshelman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frederick Frank |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director General David L. Grange |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Catherine M. Klema |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Terry Magnuson, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ernest Mario, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director John A. McNeill, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of the appointment of Deloitte & Touche LLP as the companys independent registered public accounting firm for the year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
In their discretion, the proxies are authorized to vote upon such other matters as may properly come before the annual meeting |
|
For |
|
Yes |
|
For |
|
Management |
82481R106 |
|
SHPGY |
Shire Plc |
|
|||
Meeting Date: |
4/27/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/23/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To receive the companys accounts for the year ended December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To approve the directors remuneration report for the year ended December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director Mr. David Stout |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Elect director Mr. William Burns |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
To re-appoint Deloitee LLP as auditors of the company to hold office from the conclusion of the meeting to the conclusion of the annual general meeting of the company to be held in 2011 |
|
For |
|
Yes |
|
For |
|
Management |
6 |
|
To authorize the audit, compliance & risk committee of the board to determine the remuneration of the auditors |
|
For |
|
Yes |
|
For |
|
Management |
7 |
|
To resolve that the authority to allot relevant securities (as defined in the companys articles of association) conferred on the directors by article 10 paragraph (B) of the companys articles of association be renewed and for this purpose the authorized allotment amount |
|
For |
|
Yes |
|
For |
|
Management |
8 |
|
To approve the proposed amendments (summarized in the explanatory notes to this notice) to the Shire portfolio share plan and to authorize the directors to do all such things as may be necessary to carry the same into effect |
|
For |
|
Yes |
|
For |
|
Management |
9 |
|
To resolve that, subject to the passing of the previous resolution, the authority to allot equity securities (as defined in the companys articles of association) wholly for cash, conferred on the directors by article 10 paragraph (D) of the companys articles of association be renewed, all as more fully described in the proxy statemenet |
|
For |
|
Yes |
|
For |
|
Management |
10 |
|
To resolve that the company be and is hereby generally and unconditionally authorized: (A) pursuant to article 57 of the Companies (Jersey) Law 1991 to make market purchase of ordinary shares in the capital of the company (B) pursuant to article 58A of the Companies (Jersey) Law 1991, to hold as treasury shares any ordinary shares purchased pursuant to the authority conferred by paragraph (A) of this resolution |
|
For |
|
Yes |
|
For |
|
Management |
863667101 |
|
SYK |
Stryker Corporation |
|
|||
Meeting Date: |
4/27/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/1/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Howard E. Cox, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Srikant M. Datar |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Donald M. Engelman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Louise L. Francesconi |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Howard L. Lance |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Stephen P. Macmillan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William U. Parfet |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ronda E. Stryker |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2010 |
|
For |
|
Yes |
|
For |
|
Management |
N/A N/A |
TargeGen Inc. |
|
Action by Written Consent: |
11/25/2009 |
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of amended and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of amendments to amended and restated investor rights agreement and amended and restated right of the first refusal and co-sale agreement |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
General authority |
|
For |
|
Yes |
|
For |
|
Management |
N/A N/A |
TargeGen Inc. |
|
Action by Written Consent: |
6/25/2010 |
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of amendment to merger agreement |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of amendments to amended and restated investor rights agreement and amended and restated right of the first refusal and co-sale agreement |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
General authority |
|
For |
|
Yes |
|
For |
|
Management |
881624209 |
|
TEVA |
Teva Pharmaceutical Industries Ltd. |
|
|||
Meeting Date: |
6/29/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
5/24/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To approve the board of directors recommendation that the cash dividend for year ended December 31, 2009, which was paid in four installments and aggregated NIS 2.50 (approximately $0.642, according to the applicable exchange rates) per ordinary share (or ADS), be delcared final |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Elect director Mr. Abraham E. Cohen |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Elect director Mr. Amir Elstein |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Elect director Prof. Elon Kohlberg |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Elect director Prof. Moshe Many |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Elect director Mr. Dan Propper |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as the companys independent registered public accounting firm until the 2011 annual meeting of shareholders and to authorize the board of directors to determine their compensation provided such compensation is also approved by the audit committee |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
To approve the companys 2010 long-term equity-based incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Approve remuneration of Dr. Phillip Frost, in his capacity as chairman of the board, effective as of March 9, 2010, in the amount of nis equivalent of USD 385,702 (as of March 9, 2010) per annum, plus vat (as applicable), as adjusted by the Israeli consumer price index (in addition to per meeting fees paid to directors), provision to Dr. Frost, in his capacity as chairman of the board, of an office and secretarial services, and, effective as of February 15, 2010, all as more fully, described in the proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Approve remuneration of Prof. Moshe Many, in his capacity as vice chairman of the board, effective as of March 9, 2010, in the amount of nis equivalent of USD 150,000 (as of March 9, 2010) per annum, plus vat (as applicable), as adjusted by the Israeli consumer price index (in addition to per meeting fees paid to directors), provision to Prof. Many, in his capacity as vice chairman of the board, of an office and secretarial services |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Approve remuneration of Prof. Roger Kornberg, in his capacity as a director of Teva, effective as of March 10, 2010, in the amount of nis equivalent of USD 150,000 (as of March 10, 2010) per annum, plus vat (as applicable), as adjusted by the Israeli consumer price index (in addition to per meeting fees paid to directors) |
|
For |
|
Yes |
|
For |
|
Management |
6 |
|
To approve an increase in the registered share capital of the company by nis 100,000,000 to a total of nis 250,000,000 by the creation of 1,000,000,000 additional ordinary shares of par value nis 0.1 each, and the amendment of the companys incorporation documents accordingly |
|
For |
|
Yes |
|
For |
|
Management |
91307C102 |
|
UTHR |
United Therapeutics Corporation |
|
|||
Meeting Date: |
6/28/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/29/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Christopher Causey |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard Giltner |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director R. Paul Gray |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of the amendment to amended and restated certificate of incorporation to increase authorized number of shares of common stock |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Vote to ratify Ernst & Young LLP as United Therapeutics Corporations independent registered public accounting firm for 2010 |
|
For |
|
Yes |
|
For |
|
Management |
92532F100 |
|
VRTX |
Vertex Pharmaceuticals Incorporated |
|
|||
Meeting Date: |
3/17/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
5/12/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect Director Joshua Boger |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect Director Joshua Boger Charles A. Sanders |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect Director Elaine S. Ullian |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of the amendment to the amended and restated 2006 stock and option plan the number of shares of common stock by 12,000,000. |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Vote to ratify Ernst & young LLP as Vertex Pharmaceuticals registered public accounting firm for the year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
G94368100 |
|
WCRX |
Warner Chilcott |
|
|||
Meeting Date: |
5/13/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/16/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1A |
|
Elect Director John O. Connaughton |
|
For |
|
Yes |
|
For |
|
Management |
1B |
|
Elect Director Stephen P. Murray |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Vote to ratify PricewaterhouseCoopers LLP as Warner Chilcotts independent registered public accounting firm for 2010 |
|
For |
|
Yes |
|
For |
|
Management |
94973V107 |
|
WLP |
WellPoint, Inc. |
|
|||
Meeting Date: |
5/18/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/17/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Sheila P. Burke |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect directorGeorge A. Schaffer, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jackie M. Ward |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the company for 2010 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
If properly presented at the meeting, to vote on a shareholder proposal concerning a feasibility study for converting to nonprofit status |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
4 |
|
If properly presented at the meeting, to vote on a shareholder proposal concerning disclosure of lobbying expenses |
|
Against |
|
Yes |
|
For |
|
Stockholder |
5 |
|
If properly presented at the meeting, to vote on a shareholder proposal concerning an advisory resolution on compensation of named executive officers |
|
Against |
|
Yes |
|
For |
|
Stockholder |
6 |
|
If properly presented at the meeting, to vote on a shareholder proposal to change our jurisdiction of incorporation from Indiana to Delaware |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
983024100 |
|
WYE |
Wyeth |
|
|||
Meeting Date: |
7/20/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
6/5/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Vote to adopt the agreement and plan of merger, dated as of January 25, 2009 by and among Pfizer, Inc., Wagner Acquisition Corp. and Wyeth, as it may be amended from time to time. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Vote to approve the adjournment of the meeting, if necessary, to solicit additional proxies if there are not sufficient votes to adopt the merger agreement |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director Robert M. Amen |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director Michael J. Critelli |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director Frances D. Ferguson |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director Victor F. Ganzi |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director Robert Langer |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director John P. Mascotte |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director Raymond J. McGuire |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director Mary Lake Polan |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director Bernard Poussot |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director Gary L. Rogers |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Elect director John r. Torell III |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Vote to ratify PricewaterhouseCoopers LLP as Wyeths independent registered public accounting firm for 2009 |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Stockholder proposal regarding reporting on Wyeths political contributions and trade association payments |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
6 |
|
Stockholder proposal regarding special stockholder meetings |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
98411C100 |
|
XNPT |
Xenoport, Inc. |
|
|||
Meeting Date: |
5/11/2010 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/24/2010 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Paul L. Berns |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director John G. Freund, M.D. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection by the Audit Committee of the board of directors of Ernst & Young LLP as the companys independent registered public accoutiing firm for the fiscal year ending December 31, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) |
H&Q Healthcare Investors |
||||
|
|||||
By (Signature and Title)* |
|
|
|||
|
|
(Daniel R. Omstead, President) |
|||
|
/s/ Daniel R. Omstead |
||||
|
|||||
Date |
8/31/10 |
||||
*Print the name and title of each signing officer under his or her signature.